In this issue of the ARCHIVES, Wells et al1 present data on the first randomized trial of 2 different formulations of low-molecular-weight heparin (LMWH). The question of whether these compounds are interchangeable is important for the treatment of venous thromboembolism as well as for thromboprophylaxis and treatment of acute coronary syndrome.
Zakarija A, Bennett CL. Low-Molecular-Weight Heparins: Do We Have the GUSTO to Identify Differences Between Alternative Formulations? Arch Intern Med. 2005;165(7):722–723. doi:10.1001/archinte.165.7.722
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: